Crosstree

In the complex and fast-evolving Pharma Services sector, having the right advisor makes all the difference. At Crosstree, we bring unparalleled expertise, deep industry relationships, and a track record of success in M&A, capital raising, and strategic advisory. Whether you're in discovery, preclinical, clinical development, or commercialization, our team helps navigate the evolving landscape of precision and specialty medicine, delivering tailored solutions for growth and transaction support. Connect with us to learn how Crosstree Capital can support your next strategic move: https://hubs.li/Q03gggLM0 #PharmaServices #MergersAndAcquisitions #PrivateEquity #InvestmentBanking

Crosstree’s latest Weekly Transactional Report (Week of March 23, 2025) reveals a clear signal: investor appetite for eClinical and lab services remains robust. - Over $286M in financing volume across 10 deals - Highlight transactions include: 📌 Navina raised $55M led by Goldman Sachs 📌 Mendel secured $35M Series B led by Base10 Partners 📌 Xealth received growth capital from Morningside Ventures 📌MindBio acquired Life AI Corp While M&A volume was modest this week, the sustained financing activity—especially in data-driven drug development enablement—underscores the strategic urgency across the ecosystem. Whether you are an owner/operator in the health sciences or a private equity professional operating the space, our industry insights and reports have the data you need stay on top of relevant trends in the industry. Subscribe to Crosstree insights at: https://hubs.li/Q03fQgW90 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

The February 2025 edition of our Pharma Services - Drug Supply Chain BlueBook is now available! Whether you're exploring emerging trends or planning your next big move in health sciences, the updated BlueBook format ensures the information is more accessible and impactful than ever before. Highlights from this edition include: 📌 Pii, A Jabil Company was acquired by Jabil 📌 Ionic Partners announced its acquisition of Connexion Technologies 📌 Avelios Medical closed a $31MM Series A Financing, led by Sequoia Capital, HTGF | High-Tech Gründerfonds and Revent Want to read more? Click the link below: https://hubs.li/Q03f99Nl0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

The pharma services industry is rapidly evolving with AI-driven patient recruitment transforming clinical trials by accelerating enrollment and improving trial efficiency. The acquisition of Deep 6 AI by Tempus AI leverages the strengths of both companies to enhance patient recruitment and qualification for clinical trials. By integrating Deep 6's AI and natural language processing technology, Tempus has improved their ability to access and analyze unstructured data, including physician notes, to better match patients with clinical trial criteria. Crosstree acted as a financial advisor to Deep 6 in this transaction. Read more about this #acquisition in our Deal Insights: https://hubs.li/Q03d7Q4k0 #pharmaAI #pharma #mergersandacquisitions #investmentbanking Shane Senior

Congratulations to IPeople Healthcare, an RLDatix company on its acquisition by RLDatix a portfolio company of Five Arrows and TA Associates creating an industry leader in Business Continuity and Data Accessibility for hospital and health systems. To close our 56th healthcare technology transaction, Crosstree helped IPeople identify RLDatix as the ideal partner through: 📊Presenting the client’s unique value proposition to help them achieve the optimal outcome 💡Leveraging market expertise to identify the ideal transaction partner to drive future growth globally 💲Developing and articulating a strong value proposition which connected client capabilities with market trends to weave a compelling narrative for potential buyers Read the full Deal Insights here: https://hubs.li/Q03ckN0l0 #healthcareinnovation #hcit #healthit #interoperability #mergersandacquisitions #investmentbanking Benjamin J. Garber

Congratulations to Deep 6 AI on its acquisition by Tempus AI to enhance ai-driven patient recruitment and qualification for clinical trials, accelerating drug development and trial efficiency. To close our 138th pharma services transaction, Crosstree helped Deep 6 AI identify Tempus as the ideal partner through: 📈 Ensuring Deep 6 AI was well-positioned with the right strategic opportunities and acquirers 🤝 Leveraging our network, market intelligence, and relationships to facilitate executive discussions, assess strategic fit, and ensure an informed decision 📅 Streamlining the transaction process, enabling a swift close in just over 30 days and providing market certainty for Deep 6 AI to move forward with Tempus Read the full Deal Insights here: https://hubs.li/Q03bPfvJ0 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking Shane Senior

Download the latest edition of our Diagnostics and Tools BlueBook! Discover a monthly executive review that captures the essence of valuation trends, M&A developments, and transactions in this evolving industry. Key highlights from the January 2025 edition include: 📌Akoya Biosciences, Inc. was acquired by Quanterix 📌Fremman Capital announced its acquisition of DIESSE Diagnostica Senese S.p.A. 📌Northlane Capital Partners announced its acquisition of United States Drug Testing Laboratories (USDTL) 📌SpinChip Diagnostics AS was acquired by bioMérieux Want to read more? Download using the link below: https://hubs.li/Q03bFfRf0 #InvestmentBanking #MergersAndAcquisitions #LifeSciences #PrivateEquity

We’re pleased to announce the January edition of our new Pharma Services - Pharma Technology BlueBook! Whether you're tracking the latest trends or strategizing your next major step in health sciences, the enhanced BlueBook format makes critical information more accessible and impactful than ever. Highlights from this edition include: 📌Upfront Healthcare was acquired by Health Catalyst 📌Renovaro Biosciences Inc. announced its acquisition of Predictive Oncology 📌Bioptimus closed a $41MM Series A Financing, led by True Ventures, KKR, and Bpifrance Want to read more? Click the link below: https://hubs.li/Q039pDrb0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

We’re thrilled to announce the January edition of our Pharma Services - Drug Supply Chain BlueBook! Whether you're exploring emerging trends or planning your next big move in health sciences, the updated BlueBook format ensures the information is more accessible and impactful than ever before. 📌Logility was acquired by Aptean 📌MERIT CRO announced its acquisition of OSOD, a MERIT Company 📌Nephron Pharmaceuticals closed a $350MM Financing, led by WhiteHawk Capital Partners Want to read more? Click the link below: https://hubs.li/Q038NpxC0 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews #PharmaServices

We are committed to delivering exceptional results for our clients. Feedback like this from Ascent reaffirms our dedication to providing strategic guidance and executing transformative transactions. Our team’s expertise, adaptability, and client-first approach enable us to navigate complex growth phases and achieve outstanding outcomes. Explore our success stories and discover how Crosstree can support your next strategic move: https://hubs.li/Q038jDH50 #investmentbanking #pharma #pharmaceuticalindustry #mergersandacquisitions